Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05778162 · ClinicalTrials.gov registry record
RISC Panel Remnant Sample Collection
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT05778162: Completed study, sponsored by Zimmer Biomet.
NCT05778162 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05778162 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the usability and clinical utility of the Synovasure® RISC™ Panel. The secondary objective of this study is to create a repository of well-characterized synovial fluid samples from patients with knee pain and/or inflammation to be used for future research.
Primary Outcome
This study is intended to characterize the performance of the Synovasure® RISC™ Panel in a real-world environment. The primary endpoint of this study is the rate of agreement (positive and negative) of the test result with the suspected diagnosis. The suspected diagnosis of the index knee will be collected prior to the Synovasure® RISC™ Panel analyses to be subsequently matched to the Synovasure® RISC™ Panel results.
Interventions
- DIAGNOSTIC_TEST Synovasure® RISC™ Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2024-11-12 |
What the finished NCT05778162 record still lists
NCT05778162 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Synovasure® RISC™ Panel is the first listed.
NCT05778162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05778162 about?
NCT05778162 is a clinical study titled "RISC Panel Remnant Sample Collection". The primary objective of this study is to evaluate the usability and clinical utility of the Synovasure® RISC™ Panel. The secondary objective of this study is to create a repository of well-characterized synovial fluid samples from patients with knee pain and/or inflammation to be used for future r...
What is the current status of trial NCT05778162?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2023-02-01. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT05778162?
The interventions under investigation include: Synovasure® RISC™ Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05778162?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI